- Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer
-
Cho DH, Lee SK, Kim S, Choi MY, Jung SP, Lee J, Kim J, Koo MY, Bae SY, Kim JH, Kim JS, Ho KW, Lee JE, Nam SJ, Yang JH
- KMID: 2324865
- J Korean Surg Soc.
- 2013 May;84(5):273-280.
PURPOSE: We analyzed the responses of patients with locally advanced breast cancer to neoadjuvant chemotherapy (NAC) and NAC combined with neoadjuvant human epidermal growth factor receptor-2 (HER2) targeted therapy (NCHTT). METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
